受强制性开放获取政策约束的文章 - Rebecca Miksad, MD, MPH, MMS了解详情
无法在其他位置公开访问的文章：3 篇
Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysis
SWL De Geus, DB Evans, LA Bliss, MF Eskander, JK Smith, RA Wolff, ...
European Journal of Surgical Oncology (EJSO) 42 (10), 1552-1560, 2016
强制性开放获取政策： Dutch Cancer Society
A comparison of surgical outcomes for noncirrhotic and cirrhotic hepatocellular carcinoma patients in a Western institution
RE Beard, DW Hanto, S Gautam, RA Miksad
Surgery 154 (3), 545-555, 2013
强制性开放获取政策： US National Institutes of Health
When a decision must be made: role of computer modeling in clinical cancer research
RA Miksad
Journal of Clinical Oncology 29 (35), 4602-4604, 2011
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：43 篇
Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade
PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ...
Journal of Clinical Oncology 33 (6), 550-558, 2015
强制性开放获取政策： US National Institutes of Health, Government of Spain
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
AX Zhu, DV Sahani, DG Duda, E di Tomaso, M Ancukiewicz, OA Catalano, ...
Journal of clinical oncology 27 (18), 3027-3035, 2009
强制性开放获取政策： US National Institutes of Health
cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
E Brunt, S Aishima, PA Clavien, K Fowler, Z Goodman, G Gores, A Gouw, ...
Hepatology 68 (1), 113-126, 2018
强制性开放获取政策： US National Institutes of Health
Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors
JA Chan, K Stuart, CC Earle, JW Clark, P Bhargava, R Miksad, ...
Journal of Clinical Oncology 30 (24), 2963-2968, 2012
强制性开放获取政策： US National Institutes of Health
Phase 1/2 study of everolimus in advanced hepatocellular carcinoma
AX Zhu, TA Abrams, R Miksad, LS Blaszkowsky, JA Meyerhardt, H Zheng, ...
Cancer 117 (22), 5094-5102, 2011
强制性开放获取政策： US National Institutes of Health
Quality of life implications of bisphosphonate‐associated osteonecrosis of the jaw
RA Miksad, KC Lai, TB Dodson, SB Woo, NS Treister, O Akinyemi, ...
The oncologist 16 (1), 121-132, 2011
强制性开放获取政策： US National Institutes of Health
Association of alterations in main driver genes with outcomes of patients with resected pancreatic ductal adenocarcinoma
ZR Qian, DA Rubinson, JA Nowak, V Morales-Oyarvide, RF Dunne, ...
JAMA oncology 4 (3), e173420-e173420, 2018
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Pancreatic …
Effect of high-dose vs standard-dose vitamin D3 supplementation on progression-free survival among patients with advanced or metastatic colorectal cancer: the SUNSHINE …
K Ng, HS Nimeiri, NJ McCleary, TA Abrams, MB Yurgelun, JM Cleary, ...
Jama 321 (14), 1370-1379, 2019
强制性开放获取政策： US National Institutes of Health
Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis
R Miao, H Luo, H Zhou, G Li, D Bu, X Yang, X Zhao, H Zhang, S Liu, ...
Journal of hepatology 61 (4), 840-849, 2014
强制性开放获取政策： US National Institutes of Health, 国家自然科学基金委员会
Clinical cancer advances 2017: annual report on progress against cancer from the American Society of Clinical Oncology
HJ Burstein, L Krilov, JB Aragon-Ching, NN Baxter, EG Chiorean, ...
Journal of Clinical Oncology 35 (12), 1341-1367, 2017
强制性开放获取政策： US National Institutes of Health
Stereotactic body radiotherapy (SBRT) for intrahepatic and hilar cholangiocarcinoma
A Mahadevan, N Dagoglu, J Mancias, K Raven, K Khwaja, JF Tseng, ...
Journal of Cancer 6 (11), 1099, 2015
强制性开放获取政策： US National Institutes of Health
An exploratory analysis of real-world end points for assessing outcomes among immunotherapy-treated patients with advanced non–small-cell lung cancer
M Stewart, AD Norden, N Dreyer, HJ Henk, AP Abernethy, E Chrischilles, ...
JCO clinical cancer informatics 3, 1-15, 2019
强制性开放获取政策： US National Institutes of Health, Patient-Centered Outcomes Research Institute
Progression-free survival as a surrogate endpoint in advanced breast cancer
RA Miksad, V Zietemann, R Gothe, R Schwarzer, A Conrads-Frank, ...
International journal of technology assessment in health care 24 (4), 371-383, 2008
强制性开放获取政策： US National Institutes of Health
Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival
V Morales-Oyarvide, DA Rubinson, RF Dunne, MM Kozak, JL Bui, C Yuan, ...
British journal of cancer 117 (12), 1874-1882, 2017
强制性开放获取政策： US Department of Defense, US National Institutes of Health, Pancreatic …
A phase II and biomarker study of sorafenib combined with modified FOLFOX in patients with advanced hepatocellular carcinoma
L Goyal, H Zheng, TA Abrams, R Miksad, AJ Bullock, JN Allen, ...
Clinical Cancer Research 25 (1), 80-89, 2019
强制性开放获取政策： US National Institutes of Health
Phase I and biomarker study of the Wnt pathway modulator DKN-01 in combination with gemcitabine/cisplatin in advanced biliary tract cancer
L Goyal, C Sirard, M Schrag, MH Kagey, JR Eads, S Stein, AB El-Khoueiry, ...
Clinical Cancer Research 26 (23), 6158-6167, 2020
强制性开放获取政策： US Department of Defense
Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier
MK Bhasin, K Ndebele, O Bucur, EU Yee, HH Otu, J Plati, A Bullock, X Gu, ...
Oncotarget 7 (17), 23263, 2016
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定